Newsroom
Sorted by: Latest
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 01.06.2026 FXGB LN IE00BD5HBR05 47,692.00 GBP 960,351.09 27.058 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 01.06.2026 FTFX IE00BD5HBQ97 63,402.00 USD 1,690,211.95 26.659 ...
-
How Fit Analytics Innovation Reclaimed its Independence to Build the Future of AI Commerce
BERLIN--(BUSINESS WIRE)--With today’s launch of the AI Shopping Assistant, Fit Analytics Innovation moves beyond the AI-hype-cycle to deliver the conversational guidance modern apparel shoppers crave. Two years ago, Fit Analytics Innovation did the unthinkable: they bought themselves back. Following a high-profile acquisition by Snap Inc., the management team recovered the award-winning Fit Finder and secured sixteen years of expertise and data insights. That bet on independence has culminated...
-
Payfinia Expands Embedded Instant Payment Services to the RTP® Network, Delivering Unified Fraud Controls and Payment Orchestration Across Both Real-Time Rails
PORTLAND, Ore.--(BUSINESS WIRE)--Payfinia Expands Embedded Instant Payment Services to the RTP® Network...
-
Marcus Corporation Announces Kim M. Lueck to Retire
MILWAUKEE--(BUSINESS WIRE)--Marcus Corporation (NYSE: MCS) today announced that Kim M. Lueck, chief information officer of Marcus Corporation, and chief information technology officer of Marcus Theatres, will retire on August 1, 2026, after nearly 30 years with the company. The company has initiated a process to identify the company’s next IT leader. “Over her nearly three decades with the company, Kim has made numerous important contributions to the reliability and effectiveness of our enterpr...
-
Next 15 Group plc UK Regulatory Announcement: Director/PDMR Shareholding
LONDON--(BUSINESS WIRE)-- 2 June 2026 Next 15 Group plc ("Next 15" or "the Group") NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES Grant of LTIP award On 2 June 2026, the following performance share awards (“Awards”) over Ordinary Shares were granted pursuant to an award made under the Next 15 Group plc Long-Term Incentive Plan (“LTIP”): PDMR Plan No. of Ordinary Shares subject to Award Sam Knights Next 15 Group plc Long-Term Incentive Plan 287,500 Mickey Kalifa...
-
Monro, Inc. to Participate at the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference
FAIRPORT, N.Y.--(BUSINESS WIRE)--Monro, Inc. (Nasdaq: MNRO) (“Monro”), one of the largest independent auto service and tire dealers in the United States, today announced that Peter Fitzsimmons, President and Chief Executive Officer, Brian D’Ambrosia, Executive Vice President and Chief Financial Officer and Felix Veksler, Vice President of Investor Relations, will participate in a Fireside Chat at the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference on Tuesday, June 9, 2026 at 9...
-
ENYO Pharma Appoints Jeff George as Chairman to Support Next Phase of Growth and Phase 3 Readiness
LYON, France--(BUSINESS WIRE)--ENYO Pharma (“ENYO”), a clinical-stage biotechnology company developing innovative therapies for kidney diseases, today announced the appointment of Jeff George as Non-Executive Chairman of its Board of Directors. The appointment comes as ENYO advances preparations for a pivotal Phase 3 program of Vonafexor in Alport Syndrome, a rare kidney disease, following positive Phase 2 clinical results and ahead of its End-of-Phase 2 meeting with the U.S. Food and Drug Admi...
-
Arrowhead Pharmaceuticals to Participate in Upcoming June 2026 Events
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: 2026 Jefferies Global Healthcare Conference – June 2-4, 2026 Type: Fireside Chat Presentation Date/Time: June 3, 2026, 8:10 am EDT Goldman Sachs 47th Annual Global Healthcare Conference – June 8-10, 2026 Type: Fireside Chat Presentation Date/Time: June 10, 2026, 9:00 am EDT Presentation materials and webcast links, if applicable,...